ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
TiGenix
About
TiGenix is a biomedical company focused on research and development of innovative local treatments for damaged and osteoarthritic joints.
- 101 - 250
Details
- Last Funding Type
- Private Equity（PE）
- Last Funding Money Raised
- $7.50M
- Industries
- Biotechnology,Clinical Trials,Health Care,Medical
- Founded date
- Jan 1, 2000
- Number Of Employee
- 101 - 250
- Operating Status
- Active
TiGenix NV (TiGenix) and its subsidiaries TiGenix Inc. and TC CEF LLC. is a Belgium-based biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. The Company is exploiting the power of regenerative medicine for the development of durable treatments, validated through controlled clinical studies, for these indications. TiGenix is located in Leuven and was founded as a spin-off of the Catholic University of Leuven and the University of Ghent. TiGenix is developing a portfolio of products that addresses specific musculoskeletal problems. The lead indication among these is cartilage damage, which is a debilitating affliction severely affecting the mobility and functioning of patients. During the fiscal year ended December 31, 2009, the Company acquired Orthomimetics Ltd.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 25, 2013 | Debt Financing | $13.70M | 1 | — | — | Detail |
| Jun 25, 2009 | Private Equity（PE） | $7.50M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Kreos Capital
|
— | Debt Financing |
Limburg Ventures
|
— | Private Equity（PE） |
